Annual EBITDA
-$5.53 M
+$4.63 M+45.57%
December 1, 2023
Summary
- As of February 20, 2025, CELZ annual EBITDA is -$5.53 million, with the most recent change of +$4.63 million (+45.57%) on December 1, 2023.
- During the last 3 years, CELZ annual EBITDA has risen by +$29.50 million (+84.23%).
- CELZ annual EBITDA is now -123.43% below its all-time high of $23.58 million, reached on December 31, 2021.
Performance
CELZ EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.08 M
+$515.60 K+32.31%
September 1, 2024
Summary
- As of February 20, 2025, CELZ quarterly EBITDA is -$1.08 million, with the most recent change of +$515.60 thousand (+32.31%) on September 1, 2024.
- Over the past year, CELZ quarterly EBITDA has dropped by -$68.10 thousand (-6.73%).
- CELZ quarterly EBITDA is now -103.83% below its all-time high of $28.20 million, reached on March 1, 2021.
Performance
CELZ Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$5.43 M
+$439.80 K+7.49%
September 1, 2024
Summary
- As of February 20, 2025, CELZ TTM EBITDA is -$5.43 million, with the most recent change of +$439.80 thousand (+7.49%) on September 1, 2024.
- Over the past year, CELZ TTM EBITDA has increased by +$12.80 thousand (+0.23%).
- CELZ TTM EBITDA is now -123.05% below its all-time high of $23.58 million, reached on December 1, 2021.
Performance
CELZ TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CELZ EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.6% | -6.7% | +0.2% |
| 3 y3 years | +84.2% | +4.5% | +5.4% |
| 5 y5 years | +55.0% | +4.5% | +5.4% |
CELZ EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -123.4% | +45.6% | -8.3% | +82.7% | -123.0% | +46.5% |
| 5 y | 5-year | -123.4% | +84.2% | -103.8% | +97.2% | -123.0% | +84.5% |
| alltime | all time | -123.4% | +84.2% | -103.8% | +97.2% | -123.0% | +84.5% |
Creative Medical Technology Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.08 M(-32.3%) | -$5.43 M(-7.5%) |
| Jun 2024 | - | -$1.60 M(+57.7%) | -$5.87 M(+7.8%) |
| Mar 2024 | - | -$1.01 M(-42.0%) | -$5.45 M(-0.3%) |
| Dec 2023 | -$5.53 M(-45.6%) | -$1.75 M(+14.9%) | -$5.46 M(-45.2%) |
| Sep 2023 | - | -$1.52 M(+30.0%) | -$9.97 M(+5.5%) |
| Jun 2023 | - | -$1.17 M(+13.6%) | -$9.45 M(-6.0%) |
| Mar 2023 | - | -$1.03 M(-83.6%) | -$10.05 M(-1.0%) |
| Dec 2022 | -$10.15 M(-143.1%) | -$6.25 M(+527.1%) | -$10.15 M(+89.9%) |
| Sep 2022 | - | -$997.40 K(-43.6%) | -$5.35 M(+9.9%) |
| Jun 2022 | - | -$1.77 M(+56.2%) | -$4.86 M(-15.3%) |
| Mar 2022 | - | -$1.13 M(-21.9%) | -$5.74 M(-124.4%) |
| Dec 2021 | $23.58 M(-167.3%) | - | - |
| Dec 2021 | - | -$1.45 M(+181.3%) | $23.58 M(-278.0%) |
| Sep 2021 | - | -$515.30 K(-80.5%) | -$13.25 M(+10.1%) |
| Jun 2021 | - | -$2.65 M(-109.4%) | -$12.04 M(+10.3%) |
| Mar 2021 | - | $28.20 M(-173.6%) | -$10.92 M(-68.8%) |
| Dec 2020 | -$35.03 M(+433.9%) | -$38.28 M(-5562.9%) | -$35.03 M(+2207.1%) |
| Sep 2020 | - | $700.80 K(-145.9%) | -$1.52 M(-62.9%) |
| Jun 2020 | - | -$1.53 M(-137.4%) | -$4.09 M(+91.1%) |
| Mar 2020 | - | $4.08 M(-185.5%) | -$2.14 M(-67.4%) |
| Dec 2019 | -$6.56 M(-46.5%) | -$4.77 M(+155.0%) | -$6.56 M(-1333.8%) |
| Sep 2019 | - | -$1.87 M(-544.3%) | $531.80 K(-56.2%) |
| Jun 2019 | - | $421.30 K(-224.8%) | $1.21 M(-123.3%) |
| Mar 2019 | - | -$337.50 K(-114.5%) | -$5.22 M(-57.5%) |
| Dec 2018 | -$12.27 M(+441.7%) | $2.32 M(-295.1%) | -$12.27 M(-22.7%) |
| Sep 2018 | - | -$1.19 M(-80.2%) | -$15.88 M(+8.7%) |
| Jun 2018 | - | -$6.01 M(-18.6%) | -$14.61 M(+55.2%) |
| Mar 2018 | - | -$7.39 M(+472.9%) | -$9.42 M(+315.7%) |
| Dec 2017 | -$2.27 M(+201.9%) | -$1.29 M(-1656.0%) | -$2.27 M(+94.5%) |
| Sep 2017 | - | $82.90 K(-110.1%) | -$1.16 M(-20.1%) |
| Jun 2017 | - | -$820.30 K(+244.4%) | -$1.46 M(+72.9%) |
| Mar 2017 | - | -$238.20 K(+25.8%) | -$843.00 K(+12.4%) |
| Dec 2016 | -$750.30 K | -$189.30 K(-9.8%) | -$750.30 K(+32.3%) |
| Sep 2016 | - | -$209.90 K(+2.1%) | -$567.30 K(+57.1%) |
| Jun 2016 | - | -$205.60 K(+41.3%) | -$361.10 K(+126.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$145.50 K(+2209.5%) | -$159.30 K(+665.9%) |
| Dec 2015 | -$20.80 K(+7.2%) | -$6300.00(+70.3%) | -$20.80 K(+11.2%) |
| Sep 2015 | - | -$3700.00(-2.6%) | -$18.70 K(+0.5%) |
| Jun 2015 | - | -$3800.00(-45.7%) | -$18.60 K(+1.1%) |
| Mar 2015 | - | -$7000.00(+66.7%) | -$18.40 K(-5.2%) |
| Dec 2014 | -$19.40 K(-3.5%) | -$4200.00(+16.7%) | -$19.40 K(+0.5%) |
| Sep 2014 | - | -$3600.00(0.0%) | -$19.30 K(0.0%) |
| Jun 2014 | - | -$3600.00(-55.0%) | -$19.30 K(-2.0%) |
| Mar 2014 | - | -$8000.00(+95.1%) | -$19.70 K(-2.5%) |
| Dec 2013 | -$20.10 K(0.0%) | -$4100.00(+13.9%) | -$20.20 K(-1.9%) |
| Sep 2013 | - | -$3600.00(-10.0%) | -$20.60 K(-2.4%) |
| Jun 2013 | - | -$4000.00(-52.9%) | -$21.10 K(+1.4%) |
| Mar 2013 | - | -$8500.00(+88.9%) | -$20.80 K(+3.5%) |
| Dec 2012 | -$20.10 K(+1.5%) | -$4500.00(+9.8%) | -$20.10 K(-5.2%) |
| Sep 2012 | - | -$4100.00(+10.8%) | -$21.20 K(+2.9%) |
| Jun 2012 | - | -$3700.00(-52.6%) | -$20.60 K(+1.5%) |
| Mar 2012 | - | -$7800.00(+39.3%) | -$20.30 K(+2.5%) |
| Dec 2011 | -$19.80 K(+38.5%) | -$5600.00(+60.0%) | -$19.80 K(+15.1%) |
| Sep 2011 | - | -$3500.00(+2.9%) | -$17.20 K(+4.2%) |
| Jun 2011 | - | -$3400.00(-53.4%) | -$16.50 K(+15.4%) |
| Mar 2011 | - | -$7300.00(+143.3%) | -$14.30 K(0.0%) |
| Dec 2010 | -$14.30 K(-53.3%) | -$3000.00(+7.1%) | -$14.30 K(-30.2%) |
| Sep 2010 | - | -$2800.00(+133.3%) | -$20.50 K(+1.0%) |
| Jun 2010 | - | -$1200.00(-83.6%) | -$20.30 K(-28.0%) |
| Mar 2010 | - | -$7300.00(-20.7%) | -$28.20 K(-7.8%) |
| Dec 2009 | -$30.60 K(-40.4%) | -$9200.00(+253.8%) | -$30.60 K(-8.1%) |
| Sep 2009 | - | -$2600.00(-71.4%) | -$33.30 K(-38.1%) |
| Jun 2009 | - | -$9100.00(-6.2%) | -$53.80 K(-4.1%) |
| Mar 2009 | - | -$9700.00(-18.5%) | -$56.10 K(+8.7%) |
| Dec 2008 | -$51.30 K(+277.2%) | -$11.90 K(-48.5%) | -$51.60 K(+7.1%) |
| Sep 2008 | - | -$23.10 K(+102.6%) | -$48.20 K(+63.9%) |
| Jun 2008 | - | -$11.40 K(+119.2%) | -$29.40 K(+63.3%) |
| Mar 2008 | - | -$5200.00(-38.8%) | -$18.00 K(+40.6%) |
| Dec 2007 | -$13.60 K(+871.4%) | -$8500.00(+97.7%) | -$12.80 K(+197.7%) |
| Sep 2007 | - | -$4300.00 | -$4300.00 |
| Dec 2006 | -$1400.00 | - | - |
FAQ
- What is Creative Medical Technology Holdings annual EBITDA?
- What is the all time high annual EBITDA for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings annual EBITDA year-on-year change?
- What is Creative Medical Technology Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly EBITDA year-on-year change?
- What is Creative Medical Technology Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings TTM EBITDA year-on-year change?
What is Creative Medical Technology Holdings annual EBITDA?
The current annual EBITDA of CELZ is -$5.53 M
What is the all time high annual EBITDA for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high annual EBITDA is $23.58 M
What is Creative Medical Technology Holdings annual EBITDA year-on-year change?
Over the past year, CELZ annual EBITDA has changed by +$4.63 M (+45.57%)
What is Creative Medical Technology Holdings quarterly EBITDA?
The current quarterly EBITDA of CELZ is -$1.08 M
What is the all time high quarterly EBITDA for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high quarterly EBITDA is $28.20 M
What is Creative Medical Technology Holdings quarterly EBITDA year-on-year change?
Over the past year, CELZ quarterly EBITDA has changed by -$68.10 K (-6.73%)
What is Creative Medical Technology Holdings TTM EBITDA?
The current TTM EBITDA of CELZ is -$5.43 M
What is the all time high TTM EBITDA for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high TTM EBITDA is $23.58 M
What is Creative Medical Technology Holdings TTM EBITDA year-on-year change?
Over the past year, CELZ TTM EBITDA has changed by +$12.80 K (+0.23%)